What is abdominoperineal resection (APR) for rectal cancer in adults with low rectal tumors near the anal sphincter?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 26, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Abdominoperineal Resection (APR) for Rectal Cancer

What is APR?

APR is a radical surgical procedure involving en bloc resection of the rectosigmoid, rectum, anus, surrounding mesentery, mesorectum (via total mesorectal excision), and perianal soft tissue, which necessitates creation of a permanent end colostomy. 1

Indications for APR

APR should be performed when the tumor directly involves the anal sphincter or levator muscles, or when achieving a margin-negative resection would result in loss of anal sphincter function and incontinence. 1, 2

  • For very low rectal tumors where sphincter preservation is not technically feasible, APR remains the appropriate surgical choice 3
  • The procedure is also indicated for recurrent or persistent anal carcinoma after failed chemoradiotherapy 1

Surgical Technique

The procedure incorporates meticulous total mesorectal excision (TME), which involves sharp dissection to remove the mesorectum with associated vascular and lymphatic structures, fatty tissue, and mesorectal fascia as a complete "tumor package" while sparing autonomic nerves 1, 2

Technical Variations:

  • Extralevator APR may offer benefits over conventional APR, including lower rates of intraoperative perforation, circumferential resection margin (CRM) involvement, and local recurrence, though results remain inconsistent across studies 1
  • For anal cancer, APR may require wider lateral perianal margins than required for rectal cancer 1
  • The procedure can be performed via open, laparoscopic, or robotic approaches with comparable oncological outcomes 2

Oncological Outcomes

Recent evidence suggests that worse outcomes historically attributed to APR are primarily due to tumor characteristics rather than the procedure itself:

  • A 2017 propensity score-matched SEER analysis found that after optimal adjustment for patient characteristics, APR was not identified as a risk factor for cancer-specific mortality (HR = 0.85,95% CI: 0.56-1.29, P = 0.456) 4
  • A 2024 study from the United States Rectal Cancer Consortium showed no significant difference in disease-free survival (HR = 0.90,95% CI: 0.53-1.52, P = 0.70) or overall survival (HR = 1.29,95% CI: 0.71-2.32, P = 0.39) between APR and low anterior resection for very-low rectal cancer 5

However, earlier retrospective data suggested patients with T3-T4 rectal cancer treated with APR had worse local control and overall survival compared to sphincter-preserving surgery 2

For anal carcinoma, 5-year survival rates of 39% to 66% have been observed following APR, with worse prognosis associated with node-positive disease at presentation and radiation doses <55 Gy 1

Quality of Life Considerations

Patients who undergo APR experience significantly worse body image, worse micturition symptoms, and less sexual enjoyment at 1-year post-surgery compared to those who have sphincter-preserving surgery. 1, 2, 3

  • Despite these differences, long-term overall quality of life between patients with or without a permanent colostomy appears fairly comparable in some studies 2
  • The permanent colostomy is a necessary consequence of the procedure and requires lifelong management 1, 3

Special Considerations

Wound Healing:

  • For patients undergoing APR preceded by radiation therapy (particularly for anal cancer), closure of the perineal wound using rectus abdominis myocutaneous flap reconstruction results in decreased perineal wound complications 1
  • Reconstructive tissue flaps for the perineum, such as vertical rectus or local myocutaneous flaps, should be considered 1

Postoperative Surveillance:

  • Following APR, patients should undergo re-evaluation every 3-6 months for 5 years, including clinical evaluation and inguinal node palpation 1
  • Annual chest, abdomen, and pelvis CT with contrast is recommended for 3 years 1

Common Pitfalls

  • Avoid inadequate mesorectal excision: Ensure complete TME with intact mesorectal fascia to minimize local recurrence 2, 6
  • Avoid nerve injury: Careful sharp dissection is essential to preserve autonomic nerves and maintain urinary and sexual function 1, 2
  • Avoid inadequate margins: For anal cancer, ensure wider lateral perianal margins than typically required for rectal cancer 1
  • Do not use intraoperative radiation therapy: This technique is not recommended during APR for recurrent anal cancer as it is unlikely to improve local control or survival 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Surgical Approaches for Rectal Cancer

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Colostomy Procedure for Low Rectal Cancer

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Comparison of outcomes of abdominoperineal resection vs low anterior resection in very-low rectal cancer.

Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract, 2024

Guideline

Low Anterior Resection for Rectal Carcinoma

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.